Health Catalyst, Inc. (HCAT)

Health Catalyst Statistics

Total Valuation

HCAT has a market cap or net worth of $431.41 million. The enterprise value is $408.49 million.

Market Cap	431.41M
Enterprise Value	408.49M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

HCAT has 60.85 million shares outstanding. The number of shares has increased by 6.20% in one year.

Current Share Class	60.85M
Shares Outstanding	60.85M
Shares Change (YoY)	+6.20%
Shares Change (QoQ)	+1.92%
Owned by Insiders (%)	2.84%
Owned by Institutions (%)	90.51%
Float	59.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	21.62
PS Ratio	1.38
Forward PS	1.27
PB Ratio	1.22
P/TBV Ratio	9.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.03.

Current Ratio	1.41
Quick Ratio	1.36
Debt / Equity	1.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.53

Financial Efficiency

Return on equity (ROE) is -21.46% and return on invested capital (ROIC) is -5.94%.

Return on Equity (ROE)	-21.46%
Return on Assets (ROA)	-5.26%
Return on Capital (ROIC)	-5.94%
Revenue Per Employee	$232,355
Profits Per Employee	-$60,878
Employee Count	1,300
Asset Turnover	0.40
Inventory Turnover	n/a

Taxes

Income Tax	-149,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.93% in the last 52 weeks. The beta is 1.33, so HCAT's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-23.93%
50-Day Moving Average	8.10
200-Day Moving Average	7.27
Relative Strength Index (RSI)	35.24
Average Volume (20 Days)	588,201

Short Selling Information

The latest short interest is 2.55 million, so 4.20% of the outstanding shares have been sold short.

Short Interest	2.55M
Short Previous Month	2.53M
Short % of Shares Out	4.20%
Short % of Float	4.32%
Short Ratio (days to cover)	5.03

Income Statement

In the last 12 months, HCAT had revenue of $302.06 million and -$79.14 million in losses. Loss per share was -$1.34.

Revenue	302.06M
Gross Profit	139.47M
Operating Income	-64.25M
Pretax Income	-86.06M
Net Income	-79.14M
EBITDA	-32.08M
EBIT	-64.25M
Loss Per Share	-$1.34

Balance Sheet

The company has $387.26 million in cash and $364.33 million in debt, giving a net cash position of $22.92 million or $0.38 per share.

Cash & Cash Equivalents	387.26M
Total Debt	364.33M
Net Cash	22.92M
Net Cash Per Share	$0.38
Equity (Book Value)	355.04M
Book Value Per Share	5.83
Working Capital	133.63M

Cash Flow

In the last 12 months, operating cash flow was -$955,000 and capital expenditures -$1.46 million, giving a free cash flow of -$2.41 million.

Operating Cash Flow	-955,000
Capital Expenditures	-1.46M
Free Cash Flow	-2.41M
FCF Per Share	-$0.04

Margins

Gross margin is 46.17%, with operating and profit margins of -21.27% and -26.20%.

Gross Margin	46.17%
Operating Margin	-21.27%
Pretax Margin	-26.25%
Profit Margin	-26.20%
EBITDA Margin	-10.62%
EBIT Margin	-21.27%
FCF Margin	n/a

Dividends & Yields

HCAT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.20%
Shareholder Yield	-6.20%
Earnings Yield	-18.34%
FCF Yield	-0.56%

Analyst Forecast

The average price target for HCAT is $11.75, which is 65.73% higher than the current price. The consensus rating is "Buy".

Price Target	$11.75
Price Target Difference	65.73%
Analyst Consensus	Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HCAT has an Altman Z-Score of -1.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.11
Piotroski F-Score	3